Contraceptives Flashcards
Primary MOA of hormonal contraceptives
inhibition of ovulation
hormonal components of contraceptive
estrogen (synthetic)
– ethinyl estradiol (EE)
progestins (synthetic progesterone analogs) –
levonorgestrel (LNG)
common oral OCPs
monophonic products biphasic products triphasic products quadriphonic products Progestin only (mini pill)
non contraceptive benefits of HC’s
increased hemoglobin (some OC’s contain Fe2+)
reduced risk of fetal neural tube defects (some contain folate)
decreased vasomotor symptoms (‘hot flashes”) in postmenopausal women
increased BMD in perimenopausal women
adverse effects of OCPs
venous thromboembolism (VTE)
CA
CV effects
greatest risk factors for VTE with OCPs
obesity, smokers, HTN, diabetics, recent post-op & previous DVT.
Use progestin only Has in these patients
least risk for VTE is with progestin:
levonorgestrel
CA with OCPs is mostly associated w/ ____
unopposed estrogen
lower EE increases risk of ___
failure (pregnancy)
HC users with HTN have a higher risk of ___ or ___
MI; stroke
E2 HCs are not recommended for ____, ___ or ___
smokers >35, women w/ HTN, migraines
less serious S/E of HC can be minimized/avoided by adjusting ___
E2 and or progestin content
transdermal patch that is no longer available
Evra (ortho)
transdermal patch. delivers __/__
EE/norelgestromin
administration of transdermal patch
apply 1 patch weekly x 3 weeks, then 1 week with no patch.
transdermal patch is less effective in women ___
> 90kg
vaginal ring: __/__
EE/etonogestrel
administration of vaginal ring
left in place x 3 wks
then 1 wk ring free interval
vaginal ring return to fertility after removal
rapid
with vaginal ring, users report less ___, ___,___ and ___
nausea
acne
irritability
depression
Injectable hormonal contraception dosage
Depo provera (DMPA) -- IM q3mo depo-subQ provera: SC q3mo
injectable hormonal contraception have improved. ___
adherence over OC’s